MHRA black market crackdown working

The Medicines and Healthcare products Regulatory Agency claims its efforts to stop illegal diversion of medicines to the black market are working.

The decrease in bulk orders of diverted medicines between January 2016 and March 2017 show:

  • Trading of diazepam is down by 73 per cent
  • Trading of nitrazepam is down by 30 per cent
  • Trading of top strength temazepam is down by 18 per cent
  • Trading of zolpidem is down by 18 per cent.

In an update on its investigations it revealed that, as of February 2019, 32 investigations have been initiated, and 86 suspects have been either arrested or interviewed under caution and there have been criminal convictions.

In addition 13 wholesale dealers have had their licenses discontinued or terminated and the GPhC has suspended 8 pharmacists.

In 2016, MHRA launched a major investigation into the diversion of medicines from the legal supply chain, estimated to be worth up to £200m. MHRA investigators have been tirelessly working to identify those responsible and reduce the diversion of medicines ever since.

Recommended

Scottish contractors see fine print of 2019-20 settlement

Reissner: RPS public body status may impact legal case




This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Magazine's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.